Sean Smith
Geen lopende functies
Loopbaan van Sean Smith
Eerdere bekende functies van Sean Smith
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01-04-2017 | 01-08-2019 |
| NEUROGENE INC. | Comptroller/Controller/Auditor | 01-10-2019 | 31-03-2023 |
| Financieel Directeur/CFO | 31-03-2023 | - |
Opleiding van Sean Smith
| University of Washington | Masters Business Admin |
| University of North Texas | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Sean Smith
- Ervaring
